DAFTAR PUSTAKA

1. Organization WH. The World Health Report 1996: Fighting Disease, Fostering Development: the Report of the Director-General: World Health Organization; 1996. 2. Edelman R, Levine MM. Summary of an international workshop on typoid fever. Review of infection disease;1986. 3. The sex and age distribution of the world population. 1996 revision. New Yort: united nation ; 1997 4. WHO/UNICEF Joint monitoring program for water supply and sanitation, Global water supply and sanitation assessment 2000 report. Geneva: WHO/UNICEF;2000 5. Soedarmo, S. P. S., et al. Buku Ajar Infeksi dan Pediatri Tropis,Ik Edisi Kedua :Ikatan Dokter Anak Indonesia;2008 6. Crump JA, Luby SP, Mintz ED. The global burden of typoid fever: Buletin of World Health Organization; 2004 7. Brooks, G.F., Butel, J. S. and Morse, S. A., Jawetz, Melnick & Adelberghs: Mikrobiologi Kedokteran. Buku I, Edisi I, Alih bahasa: Bagian Mikrobiologi, Jakarta :FKU Unair, Salemba Medika;2005, 8. Julius, E.S. Mikrobiologi Dasar. Jakarta : Binarupa Aksara Latar; 1990 9. Owen DM, Kulkarni R. Salmonella Infection in Emergency Medicine.2012.[diambil pada tanggal 9 februari 2013]. http://emedicine.medscape.com/article/785774-overview 10. Winn WC, Elmer W, Koneman. Konemans Colour Atlas and Textbook of Diagnostic Microbiology.United State of America: Lippincott Williams & Wilkins: 2006. 11. Dzen, SM, dkk. Bakteriologik Medik. Malang: Bayumedia;2003 12. Raffatellu M, Chessa D, Wilson RP, Tkel C, Akelik M, Bumler AJ. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun. Jan 2006;74(1):19-27.[Medline]. 13. 6 Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med. Nov 28 2002;347(22):1770-82. [Medline].[Full Text]. 14. Ramsden AE, Mota LJ, Mnter S, Shorte SL, Holden DW. The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles. Cell Microbiol. Oct 2007;9(10):2517-29. [Medline] 15. Christie AB. Infectious Diseases: Epidemiology and Clinical Practice. 4th ed. Edinburgh, Scotland: Churchill Livingstone; 1987. 16. Brusch JL, Cunha BA.Typhoid Fever.2012[dikutip http://emedicine.medscape.com/article/231135-overview 2013]: diambil dari:

17. Richard E. Behrman, Robert M. Kliegman, Ann M. Arvin; edisi bahasa Indonesia: A Samik Wahab; Ilmu Kesehatan Anak Nelson, ed.15- Jakarta: EGC;1999. 18. Tumbelaka AR. Diagnosis dan Tata laksana Demam Tifoid. Dalam Pediatrics Update. Cetakan pertama. Jakarta:Ikatan Dokter Anak Indonesia; 2003 19. Rampengan T H. Penyakit infeksi Tropis pada Anak ; edisi 2. Jakarta : EGC; 2007. 20. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ: 2006 21. Todar, K. Salmonella and Salmonellosis. Todars Online Textbook of Bacteriology. University of Wisconsin-Madison Department of Bacteriology;2005

22. Aru W, Sudoyo, dkk ; editor ; Buku Ajar Ilmu Penyakit Dalam; Jilid III, edisi IV. Jakarta : Departemen Ilmu Penyakit Dalam FK UI,: 2007 23. Sidabutar S, Satari H I. Pilihan Terapi Empiris Demam Tifoid pada Anak:Kloramfenikol atau seftriakson?. Departemen Ilmu Kesehatan Anak, RS Dr Cipto Mangunkusumo, Fakultas Kedokteran Universitas Indonesia. Jakarta: Sari Pediatri;2010 24. Watson KC. Chloramphenicol in typhoid fever: a review of 110 cases. American Journal of Tropic Medicine Hygine 25. Harrison CJ. BRATCHER, Denise. Cephalosporins A review.Pediatrics in review; 2008. 26. Acharya G, Revoisier C, Butler T, Ho M, Tiwari M, Klaus SK, dkk. Pharmacokinetics of ceftriaxone. Antimikcrob Agents Chemother; 1998 27. Acharya G, Buttler T, Ho M, Sharma PR, Tiwari M, Adhikari RK dkk. Treatment of typhoid fever: randomized trial of a three-day course of Ceftriaxone versus a fourteen day course of chloramphenicol; 1995 28 Musnelina L, Afdhal AF, Gani A, Andayani P. Analisis efektivitas biaya pengobatan demam tifoid anak menggunakan kloramfenikol dan seftriakson di rumah sakit Fatmawati Jakarta tahun 2001-2002. Makara; 2004 29 Islam A, Buttler T, Kabir I, Alam NH. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial. Antimicrob. Agents Chemother 1993 30. Moosa A, Rubidge CJ. Once daily ceftriaxone vs chloramphenicol for treatment of typhoid fever inchildren. Pediatr Infection Disease Journal 31. World Health Organization Department of Vaccines and Biologicals. Background document: the diagnosis, prevention and treatment of typhoid fever. Geneva: WHO, 2003:19-23. (www.who.int/entity/vaccine_research/ documents/en/typhoid_diagnosis.pdf. ) 32 Van den Bergh ET, Gasem MH, Keuter M, Dolmans MV. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop Med Int Health 1999;4:211-5. 33. Engels EA. Falagas ME. Lau J.Bennish ML. Paper: Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity:BMJ; 1998 34. Rampengan TH, satari HI. Pedoman Imunisasi Di Indonesia. Ed keempat. Jakarta:satgas imunisasi Ikatan Dokter Anak Indonesia;2011.